Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 2,590 shares at $77.35 ($200K) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Seasonal sale ($200k) by Director — this insider has traded RGEN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.35 | 1,295 | $100K | 50.0% |
| 2 | $77.35 | 1,295 | $100K | 50.0% |
| Total | $77.35 avg | 2,590 | $200K | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |